The global intrathecal pumps market size was estimated to be USD 361.7 Million in 2023 and is expected to reach USD 637.1 Million by 2034 with a CAGR of 5.28% during the forecast period 2024-2034. The market will increase as a result of factors such as the rising prevalence of chronic pain, improvements in intrathecal pump technology, growing applications in neurological disorders, rising awareness and acceptance, and partnerships and collaborations.
Growth in the intrathecal pump market may be fueled by ongoing developments in the technology, such as enhanced remote monitoring capabilities, medication delivery systems, and pump design. Patients and healthcare professionals may be drawn to innovations that improve intrathecal pump therapy's safety, effectiveness, and convenience. For instance, in October 2023, Medtronic plc purchased the spine division of Align Technology, which included the Intellis platform for intrathecal pain treatment and spinal neurostimulation.
By product class, the baclofen segment accounted for the highest revenue-grossing segment in the global intrathecal pumps market in 2023 owing to the increasing prevalence of spasticity-related conditions, a growing aging population, and the expanding applications of baclofen pumps in the effective management of neurological disorders. For instance, Flowonix Medical Inc. introduced its next-generation LDR Plus intrathecal pain pump with enhanced patient programming choices and a larger medication reservoir capacity in August 2023. Additionally, the hydromorphone segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for potent analgesics in pain management, the increasing prevalence of chronic pain conditions, and the efficacy of hydromorphone in providing effective pain relief.
By application, the pain management segment accounted for the highest revenue-grossing segment in the global intrathecal pumps market in 2023 owing to the escalating prevalence of chronic pain disorders, an expanding aging population seeking effective pain relief, and the growing acceptance of intrathecal pumps as a targeted and efficient means of pain management. For instance, Codman & Shurtleff, Inc. introduced its Proclaim DRG intrathecal drug delivery system in September 2023, which has enhanced refill port technology to provide faster and simpler medicine refills. Additionally, the spasticity management segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing incidence of neurological disorders leading to spasticity, a growing awareness of intrathecal pumps as an effective treatment modality for spasticity management, and ongoing advancements in pump technology enhancing the precision and efficiency of drug delivery.
By end-user, the hospitals & clinics segment accounted for the highest revenue-grossing segment in the global intrathecal pumps market in 2023 owing to the increasing adoption of intrathecal pump therapy as a standard and advanced form of patient care in hospital settings. For instance, Tricumed Medizintechnik GmbH's iQ med pump, a programmable intrathecal medication administration system with an integrated pressure sensor for better drug delivery monitoring, received CE Mark approval in November 2023. Additionally, the ambulatory surgery centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend towards outpatient procedures, the rising emphasis on cost-effective and efficient healthcare delivery, and the advancements in intrathecal pump technology allowing for safer and more accessible procedures in ambulatory settings.
North American region is anticipated to have the highest revenue share during the forecast period owing to the robust healthcare infrastructure, increasing prevalence of chronic pain conditions, high adoption rate of advanced medical technologies, and favorable reimbursement policies. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing healthcare infrastructure development, rising awareness about advanced medical treatments, and the growing prevalence of chronic pain conditions and neurological disorders. For instance, Teleflex Incorporated introduced the FlexFlow+ intrathecal catheter in December 2023, which has better medicine administration to the spinal cord and increased kink resistance.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Growth in the intrathecal pump market may be fueled by ongoing developments in the technology, such as enhanced remote monitoring capabilities, medication delivery systems, and pump design. Patients and healthcare professionals may be drawn to innovations that improve intrathecal pump therapy's safety, effectiveness, and convenience. For instance, in October 2023, Medtronic plc purchased the spine division of Align Technology, which included the Intellis platform for intrathecal pain treatment and spinal neurostimulation.
By product class, the baclofen segment accounted for the highest revenue-grossing segment in the global intrathecal pumps market in 2023 owing to the increasing prevalence of spasticity-related conditions, a growing aging population, and the expanding applications of baclofen pumps in the effective management of neurological disorders. For instance, Flowonix Medical Inc. introduced its next-generation LDR Plus intrathecal pain pump with enhanced patient programming choices and a larger medication reservoir capacity in August 2023. Additionally, the hydromorphone segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for potent analgesics in pain management, the increasing prevalence of chronic pain conditions, and the efficacy of hydromorphone in providing effective pain relief.
By application, the pain management segment accounted for the highest revenue-grossing segment in the global intrathecal pumps market in 2023 owing to the escalating prevalence of chronic pain disorders, an expanding aging population seeking effective pain relief, and the growing acceptance of intrathecal pumps as a targeted and efficient means of pain management. For instance, Codman & Shurtleff, Inc. introduced its Proclaim DRG intrathecal drug delivery system in September 2023, which has enhanced refill port technology to provide faster and simpler medicine refills. Additionally, the spasticity management segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing incidence of neurological disorders leading to spasticity, a growing awareness of intrathecal pumps as an effective treatment modality for spasticity management, and ongoing advancements in pump technology enhancing the precision and efficiency of drug delivery.
By end-user, the hospitals & clinics segment accounted for the highest revenue-grossing segment in the global intrathecal pumps market in 2023 owing to the increasing adoption of intrathecal pump therapy as a standard and advanced form of patient care in hospital settings. For instance, Tricumed Medizintechnik GmbH's iQ med pump, a programmable intrathecal medication administration system with an integrated pressure sensor for better drug delivery monitoring, received CE Mark approval in November 2023. Additionally, the ambulatory surgery centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend towards outpatient procedures, the rising emphasis on cost-effective and efficient healthcare delivery, and the advancements in intrathecal pump technology allowing for safer and more accessible procedures in ambulatory settings.
North American region is anticipated to have the highest revenue share during the forecast period owing to the robust healthcare infrastructure, increasing prevalence of chronic pain conditions, high adoption rate of advanced medical technologies, and favorable reimbursement policies. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing healthcare infrastructure development, rising awareness about advanced medical treatments, and the growing prevalence of chronic pain conditions and neurological disorders. For instance, Teleflex Incorporated introduced the FlexFlow+ intrathecal catheter in December 2023, which has better medicine administration to the spinal cord and increased kink resistance.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product Class, Application, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Intrathecal Pumps Market Report 2023 - 2034
Intrathecal Pumps Market Analysis & Forecast by Product Class 2023 - 2034 (Revenue USD Mn)
- Baclofen
- Hydromorphone
- Morphine
- Bupivacaine
- Other Types
Intrathecal Pumps Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Mn)
- Pain Management
- Spasticity Management
Intrathecal Pumps Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Mn)
- Hospitals & Clinics
- Ambulatory Surgery Centers
Intrathecal Pumps Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Intrathecal Pumps Market: Product ClassEstimates & Trend Analysis
8. Intrathecal Pumps Market: Application Estimates & Trend Analysis
9. Intrathecal Pumps Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Intrathecal Pumps Market
12. Europe Global Intrathecal Pumps Market
13. Asia Pacific Global Intrathecal Pumps Market
14. Latin America Global Intrathecal Pumps Market
15. MEA Global Intrathecal Pumps Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Medtronic plc
- Flowonix Medical Inc.
- Codman & Shurtleff Inc. (a Johnson & Johnson company)
- Tricumed Medizintechnik GmbH
- Teleflex Incorporated
- Compagnie de Saint-Gobain S.A.
- B. Braun Melsungen AG
- Smiths Medical
- DePuy Synthes (a Johnson & Johnson company)
- Advanced Bionics (a subsidiary of Sonova Holding AG)
- Nevro Corp
- Boston Scientific Corporation
- Kimberly-Clark Corporation
- Hospira Inc. (a Pfizer company)
- Stryker Corporation.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 361.7 Million |
| Forecasted Market Value ( USD | $ 637.1 Million |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
